Patents Assigned to Cymabay Therapeutics, Inc.
  • Treatment of intrahepatic cholestatic diseases
    Patent number: 11596614
    Abstract: Treatment of intrahepatic cholestatic diseases by therapy with seladelpar or a salt thereof.
    Type: Grant
    Filed: April 3, 2021
    Date of Patent: March 7, 2023
    Assignee: CymaBay Therapeutics, Inc.
    Inventors: Pol Boudes, Charles A. McWherter
  • Treatment of intrahepatic cholestatic diseases
    Patent number: 11406611
    Abstract: Treatment of intrahepatic cholestatic diseases by therapy with MBX-8025 or an MBX-8025 salt.
    Type: Grant
    Filed: October 3, 2020
    Date of Patent: August 9, 2022
    Assignee: CymaBay Therapeutics, Inc.
    Inventors: Pol Boudes, Charles A. McWherter
  • Treatment of cholangiopathies
    Publication number: 20220241228
    Abstract: Seladelpar and its salts are useful in the treatment of cholangiopathies in subjects who are intolerant of, or have an inadequate response to, obeticholic acid and/or fibrates.
    Type: Application
    Filed: January 29, 2022
    Publication date: August 4, 2022
    Applicant: CymaBay Therapeutics, Inc.
    Inventors: Yun-Jung Choi, Charles A. McWherter, Alexandra S. Steinberg, Ke Yang
  • Treatment of intrahepatic cholestatic diseases
    Patent number: 11224580
    Abstract: Treatment of intrahepatic cholestatic diseases by therapy with seladelpar or a salt thereof.
    Type: Grant
    Filed: September 18, 2020
    Date of Patent: January 18, 2022
    Assignee: CymaBay Therapeutics, Inc.
    Inventors: Pol Boudes, Charles A. McWherter
  • Treatment of NAFLD and NASH
    Patent number: 11179359
    Abstract: Treatment of NAFLD and NASH by therapy with MBX-8025 or an MBX-8025 salt.
    Type: Grant
    Filed: June 19, 2020
    Date of Patent: November 23, 2021
    Assignee: CymaBay Therapeutics, Inc.
    Inventors: Brian Roberts, Xueyan Wang, Yun-Jung Choi, David Karpf, Robert Martin, Charles McWherter
  • CB-0406 choline salt
    Publication number: 20210355066
    Abstract: CB-0406 choline salt, especially in crystalline form and as an ansolvate, methods of preparing it, compositions containing it, and its pharmaceutical uses.
    Type: Application
    Filed: May 12, 2021
    Publication date: November 18, 2021
    Applicants: CymaBay Therapeutics, Inc., DiaTex, Inc.
    Inventors: Stephan X.M. Boerrigter, Charles A. McWherter, Robert L. Martin, Jennifer L. Nelson, Jiangao Song
  • CB-0406 tromethamine salt
    Publication number: 20210355065
    Abstract: CB-0406 tromethamine salt, especially in crystalline form and as an ansolvate, methods of preparing it, compositions containing it, and its pharmaceutical uses.
    Type: Application
    Filed: May 12, 2021
    Publication date: November 18, 2021
    Applicants: CymaBay Therapeutics, Inc., DiaTex, Inc.
    Inventors: Stephan X.M. Boerrigter, Charles A. McWherter, Robert L. Martin, Jennifer L. Nelson, Jiangao Song
  • Treatment of cholestatic pruritus
    Publication number: 20210283078
    Abstract: Treatment of cholestatic pruritus by therapy with seladelpar or a salt thereof.
    Type: Application
    Filed: December 21, 2020
    Publication date: September 16, 2021
    Applicant: CymaBay Therapeutics, Inc.
    Inventors: Pol Boudes, Charles A. McWherter, Alexandra S. Steinberg
  • Treatment of intrahepatic cholestatic diseases
    Publication number: 20210220305
    Abstract: Treatment of intrahepatic cholestatic diseases by therapy with seladelpar or a salt thereof.
    Type: Application
    Filed: April 3, 2021
    Publication date: July 22, 2021
    Applicant: CymaBay Therapeutics, Inc.
    Inventors: Pol Boudes, Charles A. McWherter
  • Treatment of alcoholic liver disease
    Publication number: 20210145774
    Abstract: Treatment of alcoholic liver disease with seladelpar or a salt thereof.
    Type: Application
    Filed: November 12, 2020
    Publication date: May 20, 2021
    Applicant: CymaBay Therapeutics, Inc.
    Inventor: Edward E. Cable
  • Treatment of intestinal barrier dysfunction and associated diseases
    Publication number: 20210145775
    Abstract: Treatment of intestinal barrier dysfunction and associated diseases other than alcoholic liver disease or NAFLD/NASH with seladelpar or a salt thereof.
    Type: Application
    Filed: November 12, 2020
    Publication date: May 20, 2021
    Applicant: CymaBay Therapeutics, Inc.
    Inventor: Edward E. Cable
  • Methods of reducing small, dense LDL particles
    Patent number: 11007162
    Abstract: The present invention provides methods for increasing LDL particle size.
    Type: Grant
    Filed: October 31, 2018
    Date of Patent: May 18, 2021
    Assignee: CymaBay Therapeutics, Inc.
    Inventors: David Karpf, Ronald M. Krauss, Yun-Jung Choi, Xueyan Wang, Francine M. Gregoire
  • Treatment of intrahepatic cholestatic diseases
    Patent number: 11000494
    Abstract: Treatment of intrahepatic cholestatic diseases by therapy with seladelpar or a salt thereof.
    Type: Grant
    Filed: September 18, 2020
    Date of Patent: May 11, 2021
    Assignee: CymaBay Therapeutics, Inc.
    Inventors: Pol Boudes, Charles A. McWherter
  • Treatment of NAFLD and NASH
    Publication number: 20210038546
    Abstract: Treatment of NAFLD and NASH by therapy with MBX-8025 or an MBX-8025 salt.
    Type: Application
    Filed: June 19, 2020
    Publication date: February 11, 2021
    Applicant: CymaBay Therapeutics, Inc.
    Inventors: Brian Roberts, Xueyan Wang, Yun-Jung Choi, David Karpf, Robert Martin, Charles McWherter
  • Treatment of intrahepatic cholestatic diseases
    Publication number: 20210023031
    Abstract: Treatment of intrahepatic cholestatic diseases by therapy with MBX-8025 or an MBX-8025 salt.
    Type: Application
    Filed: October 3, 2020
    Publication date: January 28, 2021
    Applicant: CymaBay Therapeutics, Inc.
    Inventors: Pol Boudes, Charles A. McWherter
  • Treatment of intrahepatic cholestatic diseases
    Publication number: 20210000774
    Abstract: Treatment of intrahepatic cholestatic diseases by therapy with seladelpar or a salt thereof.
    Type: Application
    Filed: September 18, 2020
    Publication date: January 7, 2021
    Applicant: CymaBay Therapeutics, Inc.
    Inventors: Pol Boudes, Charles A. McWherter
  • Treatment of intrahepatic cholestatic diseases
    Publication number: 20210000773
    Abstract: Treatment of intrahepatic cholestatic diseases by therapy with seladelpar or a salt thereof.
    Type: Application
    Filed: September 18, 2020
    Publication date: January 7, 2021
    Applicant: CymaBay Therapeutics, Inc.
    Inventors: Pol Boudes, Charles A. McWherter
  • Treatment of intrahepatic cholestatic diseases
    Patent number: 10828273
    Abstract: Treatment of intrahepatic cholestatic diseases by therapy with MBX-8025 or an MBX-8025 salt.
    Type: Grant
    Filed: December 17, 2018
    Date of Patent: November 10, 2020
    Assignee: CymaBay Therapeutics, Inc.
    Inventors: Pol Boudes, Charles A. McWherter
  • Treatment of intrahepatic cholestatic diseases
    Patent number: 10813896
    Abstract: Treatment of intrahepatic cholestatic diseases by therapy with seladelpar or a salt thereof.
    Type: Grant
    Filed: November 6, 2019
    Date of Patent: October 27, 2020
    Assignee: CymaBay Therapeutics, Inc.
    Inventors: Pol Boudes, Charles A. McWherter
  • Treatment of intrahepatic cholestatic diseases
    Patent number: 10813895
    Abstract: Treatment of intrahepatic cholestatic diseases by therapy with seladelpar or a salt thereof.
    Type: Grant
    Filed: October 9, 2019
    Date of Patent: October 27, 2020
    Assignee: CymaBay Therapeutics, Inc.
    Inventors: Pol Boudes, Charles A. McWherter